5,7-dihydroxytryptamine has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berg, KA; Clarke, WP; De Deurwaerdère, P; Navailles, S; Spampinato, U | 1 |
Costentin, J; Le Maître, E; Leroux-Nicollet, I; Vilpoux, C | 1 |
2 other study(ies) available for 5,7-dihydroxytryptamine and guanosine 5'-o-(3-thiotriphosphate)
Article | Year |
---|---|
Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens.
Topics: 5,7-Dihydroxytryptamine; Aminopyridines; Animals; CHO Cells; Cricetinae; Dopamine; Dose-Response Relationship, Drug; Ethylamines; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Indoles; Ligands; Male; Microdialysis; Neostriatum; Neural Inhibition; Neural Pathways; Nucleus Accumbens; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists | 2004 |
Opioid receptor-like 1 (NOP) receptors in the rat dorsal raphe nucleus: evidence for localization on serotoninergic neurons and functional adaptation after 5,7-dihydroxytryptamine lesion.
Topics: 5,7-Dihydroxytryptamine; Adaptation, Physiological; Animals; Autoradiography; Citalopram; Denervation; Guanosine 5'-O-(3-Thiotriphosphate); Male; Neurons; Nociceptin; Nociceptin Receptor; Opioid Peptides; Radioligand Assay; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Sulfur Radioisotopes; Tritium | 2005 |